Prospects for Manipulation of Mesenchymal Stem Cells in Tumor Therapy: Anti-Angiogenesis Property on the Spotlight.
Angiogenesis
Cancer therapy
Mesenchymal stem cells
Tumor microenvironment
Journal
International journal of stem cells
ISSN: 2005-3606
Titre abrégé: Int J Stem Cells
Pays: Korea (South)
ID NLM: 101497587
Informations de publication
Date de publication:
30 Nov 2021
30 Nov 2021
Historique:
received:
16
09
2020
revised:
01
06
2021
accepted:
16
06
2021
pubmed:
31
8
2021
medline:
31
8
2021
entrez:
30
8
2021
Statut:
ppublish
Résumé
The interactions between the tumor microenvironment and the tumor cells confers a condition that accelerate or decelerate the development of tumor. Of these cells, mesenchymal stem cells (MSCs) have the potential to modulate the tumor cells. MSCs have been established with double functions, whereby contribute to a tumorigenic or anti-tumor setting. Clinical studies have indicated the potential of MSCs to be used as tool in treating the human cancer cells. One of the advantageous features of MSCs that make them as a well-suited tool for cancer therapy is the natural tumor-trophic migration potential. A key specification of the tumor development has been stablished to be angiogenesis. As a result, manipulation of angiogenesis has become an attractive approach for cancer therapy. This review article will seek to clarify the anti-angiogenesis strategy in modulating the MSCs to treat the tumor cells.
Identifiants
pubmed: 34456189
pii: ijsc20146
doi: 10.15283/ijsc20146
pmc: PMC8611310
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
351-365Références
Nat Med. 2001 Apr;7(4):393-5
pubmed: 11283651
Stem Cells. 2006 May;24(5):1294-301
pubmed: 16410387
Front Oncol. 2019 Aug 28;9:840
pubmed: 31555593
Gene Ther. 2008 May;15(10):730-8
pubmed: 18401438
Front Cell Dev Biol. 2016 Aug 22;4:83
pubmed: 27597941
Stem Cell Res Ther. 2013 Jun 13;4(3):70
pubmed: 23763837
Br J Haematol. 2000 Apr;109(1):235-42
pubmed: 10848804
Transplantation. 1968 Mar;6(2):230-47
pubmed: 5654088
Annu Rev Cell Dev Biol. 1995;11:73-91
pubmed: 8689573
Prostate. 1999 Jul 1;40(2):115-24
pubmed: 10386472
Stem Cells Dev. 2013 Mar 1;22(5):758-71
pubmed: 23034046
Nature. 1993 Apr 29;362(6423):841-4
pubmed: 7683111
Oncotarget. 2014 Sep 15;5(17):7575-88
pubmed: 25277190
J Thorac Oncol. 2011 Aug;6(8):1418-25
pubmed: 21597387
Front Cell Dev Biol. 2020 Mar 12;8:149
pubmed: 32226787
Anticancer Agents Med Chem. 2018;18(14):1991-2005
pubmed: 30088452
J Exp Med. 2006 May 15;203(5):1235-47
pubmed: 16636132
Pathobiology. 2012;79(6):290-306
pubmed: 22688186
Stem Cells. 2006 May;24(5):1254-64
pubmed: 16410389
Naturwissenschaften. 1996 Apr;83(4):153-64
pubmed: 8643122
Exp Hematol Oncol. 2013 Jul 01;2(1):17
pubmed: 23815814
Nat Rev Cancer. 2008 Aug;8(8):579-91
pubmed: 18596824
Stem Cells. 2006 Apr;24(4):1020-9
pubmed: 16339642
Nature. 2001 Apr 5;410(6829):701-5
pubmed: 11287958
Cancer Res. 2011 Jul 15;71(14):4758-68
pubmed: 21613405
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Jpn J Cancer Res. 1994 Oct;85(10):1045-9
pubmed: 7525523
N Engl J Med. 2006 Dec 14;355(24):2542-50
pubmed: 17167137
N Engl J Med. 2004 Jun 3;350(23):2335-42
pubmed: 15175435
Gene Ther. 2004 Jul;11(14):1155-64
pubmed: 15141157
Oncotarget. 2011 Mar;2(3):122-34
pubmed: 21399234
Semin Oncol. 1988 Apr;15(2 Suppl 1):14-9
pubmed: 3285481
Cancer Cell. 2008 Jun;13(6):554-6
pubmed: 18538738
Blood. 2007 Nov 15;110(10):3499-506
pubmed: 17664353
Biochem J. 2010 Apr 28;428(1):11-23
pubmed: 20423328
Biochem Biophys Res Commun. 1989 Jun 15;161(2):851-8
pubmed: 2735925
Cytotherapy. 2009;11(3):289-98, 1 p following 298
pubmed: 19308770
Future Oncol. 2011 Nov;7(11):1247-53
pubmed: 22044199
Cancer Sci. 2017 Oct;108(10):1939-1946
pubmed: 28756624
J Gene Med. 2011 Mar;13(3):171-80
pubmed: 21449040
Nature. 2002 Jul 4;418(6893):41-9
pubmed: 12077603
JAMA. 2002 Jul 17;288(3):321-33
pubmed: 12117397
Blut. 1987 Jun;54(6):351-9
pubmed: 3496136
Cell Biol Int. 2008 Jan;32(1):8-15
pubmed: 17904875
J Cell Physiol. 2019 Nov;234(11):21359-21368
pubmed: 31032951
J Embryol Exp Morphol. 1966 Dec;16(3):381-90
pubmed: 5336210
PLoS One. 2012;7(7):e39119
pubmed: 22911684
Mol Cancer. 2015 Jan 27;14:14
pubmed: 25623255
Cancer Lett. 2009 Aug 18;281(1):32-41
pubmed: 19342158
Lancet Oncol. 2008 Apr;9(4):376-84
pubmed: 18374291
Cancer Lett. 2018 Apr 10;419:30-39
pubmed: 29331419
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18117-22
pubmed: 15608062
Blood. 2013 Oct 3;122(14):e23-32
pubmed: 23980067
Nature. 1989 May 4;339(6219):58-61
pubmed: 2469964
Stem Cells Dev. 2012 Feb 10;21(3):476-86
pubmed: 21513440
Leukemia. 2007 Feb;21(2):304-10
pubmed: 17170725
Shock. 2021 Apr 1;55(4):423-440
pubmed: 32826813
J Biol Chem. 1995 Jan 20;270(3):1230-7
pubmed: 7836384
Cancer Cell. 2007 Jan;11(1):83-95
pubmed: 17222792
PLoS One. 2013 Dec 31;8(12):e84256
pubmed: 24391924
Science. 2005 Jan 7;307(5706):58-62
pubmed: 15637262
PLoS One. 2008 Jun 25;3(6):e2563
pubmed: 18575622
Haematologica. 2007 Apr;92(4):440-9
pubmed: 17488654
J Clin Oncol. 2009 Jul 1;27(19):3126-32
pubmed: 19451427
Cytotherapy. 2005;7(1):36-45
pubmed: 16040382
EBioMedicine. 2018 Mar;29:128-145
pubmed: 29503225
N Engl J Med. 2007 Dec 27;357(26):2666-76
pubmed: 18160686
Stem Cells Dev. 2013 May 1;22(9):1370-86
pubmed: 23231075
Stem Cell Res Ther. 2013 Apr 25;4(2):34
pubmed: 23618405
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
J Cancer Res Clin Oncol. 2015 May;141(5):909-21
pubmed: 25373315
Cancer Cell. 2009 Mar 3;15(3):220-31
pubmed: 19249680
Cancer Res. 2005 Apr 15;65(8):3307-18
pubmed: 15833864
Mol Endocrinol. 1999 Jun;13(6):806-11
pubmed: 10379879
Mol Hum Reprod. 2013 Feb;19(2):72-81
pubmed: 23075882
Cell Mol Life Sci. 1999 Apr;55(4):663-7
pubmed: 10357234
Cancer Lett. 2012 Feb 1;315(1):28-37
pubmed: 22055459
Prostate. 2010 Jul 1;70(10):1066-73
pubmed: 20232361
Cancer Lett. 2008 Sep 28;269(1):67-77
pubmed: 18571836
Clin Pharmacol Ther. 2012 Jan;91(1):71-80
pubmed: 22158569
Mol Ther. 2009 Jan;17(1):183-90
pubmed: 18985030
Nature. 2007 Oct 4;449(7162):557-63
pubmed: 17914389
Cell Res. 2008 Apr;18(4):500-7
pubmed: 18364678
J Reprod Fertil Suppl. 1999;54:181-91
pubmed: 10692854
Thorax. 2010 Apr;65(4):362-9
pubmed: 20388765
Vet Clin North Am Equine Pract. 2011 Aug;27(2):243-61
pubmed: 21872757
J Cell Physiol. 2019 Mar;234(3):2134-2142
pubmed: 30317611
J Cell Physiol. 2019 Feb;234(2):1560-1566
pubmed: 30132854
Gastroenterology. 2011 Sep;141(3):1046-56
pubmed: 21699785
Br J Cancer. 2012 Jun 5;106(12):1901-6
pubmed: 22596239
Nat Med. 2004 Sep;10(9):942-9
pubmed: 15322536
Nature. 2004 Nov 18;432(7015):294-7
pubmed: 15549090
Eur J Obstet Gynecol Reprod Biol. 2003 Sep 22;110 Suppl 1:S10-8
pubmed: 12965086
J Cell Mol Med. 2004 Jul-Sep;8(3):294-300
pubmed: 15491505
ACS Nano. 2021 Feb 23;15(2):3251-3263
pubmed: 33481565
Blood. 2003 May 1;101(9):3597-605
pubmed: 12531805
Endocrinology. 1997 Mar;138(3):863-70
pubmed: 9048584
Cancer Res. 2009 Feb 15;69(4):1255-8
pubmed: 19208837
Front Med (Lausanne). 2015 Jul 22;2:47
pubmed: 26258125
Neuro Oncol. 2010 May;12(5):453-65
pubmed: 20406896
J Cell Biochem. 2001;82(4):583-90
pubmed: 11500936
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Cell Death Differ. 2015 Jan;22(1):34-45
pubmed: 25236394
Clin Cancer Res. 2003 Jun;9(6):1980-9
pubmed: 12796359
J Biol Chem. 1999 Jan 22;274(4):2185-92
pubmed: 9890981
Mol Med. 2011;17(7-8):579-87
pubmed: 21424106
Br J Cancer. 2008 Dec 16;99(12):2006-12
pubmed: 19078952
Endocr Relat Cancer. 2000 Jun;7(2):85-93
pubmed: 10903526
J Neuroimmunol. 2010 Aug 25;225(1-2):195-9
pubmed: 20537408
Leukemia. 2009 May;23(5):925-33
pubmed: 19148141
Int J Mol Sci. 2015 Dec 16;16(12):30015-33
pubmed: 26694366
Int J Oncol. 2012 Jan;40(1):163-9
pubmed: 21971610
Oncol Lett. 2016 Feb;11(2):1089-1094
pubmed: 26893697
Cancer Res. 2004 Jun 1;64(11):3731-6
pubmed: 15172975
Clin Cancer Res. 2008 Oct 15;14(20):6371-5
pubmed: 18927275
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Cancer Invest. 2018 Jan 2;36(1):37-58
pubmed: 29336624
Ann Med. 2005;37(7):469-79
pubmed: 16278160
Annu Rev Pathol. 2014;9:47-71
pubmed: 23937437
N Engl J Med. 1971 Nov 18;285(21):1182-6
pubmed: 4938153
Clin Cancer Res. 2011 Nov 15;17(22):7156-63
pubmed: 21976547
Nat Rev Neurosci. 2007 Aug;8(8):610-22
pubmed: 17643088
PLoS One. 2012;7(9):e45590
pubmed: 23029122
PLoS One. 2009 Aug 19;4(8):e6695
pubmed: 19690611
Adv Drug Deliv Rev. 2012 Jun 1;64(8):739-48
pubmed: 21740940
Cancer Res. 2001 Mar 15;61(6):2404-8
pubmed: 11289105
Leukemia. 2006 May;20(5):847-56
pubmed: 16453000
Nat Med. 2003 Jun;9(6):669-76
pubmed: 12778165
PLoS One. 2010 Jun 16;5(6):e11140
pubmed: 20585401
J Clin Invest. 2011 Apr;121(4):1313-28
pubmed: 21436589
PLoS One. 2006 Dec 27;1:e116
pubmed: 17205120
Nat Clin Pract Oncol. 2006 Dec;3(12):682-92
pubmed: 17139319
Ann Oncol. 2006 May;17(5):866-73
pubmed: 16500908
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11393-8
pubmed: 12177445
Contrib Nephrol. 2011;170:83-92
pubmed: 21659761
Blood. 2009 Apr 30;113(18):4197-205
pubmed: 19036701
N Engl J Med. 2008 May 8;358(19):2039-49
pubmed: 18463380
Mol Cancer. 2017 Feb 1;16(1):31
pubmed: 28148268
Cancer Res. 1997 Oct 15;57(20):4593-9
pubmed: 9377574
Small. 2018 Apr;14(15):e1704008
pubmed: 29516679
Cancer Biol Ther. 2008 Feb;7(2):245-51
pubmed: 18059192
PLoS One. 2010 Jul 28;5(7):e11813
pubmed: 20676365
Cell Commun Signal. 2016 Sep 08;14(1):20
pubmed: 27608835
Cancer Lett. 2011 Sep 1;308(1):91-9
pubmed: 21601983
Nat Med. 2009 Apr;15(4):425-35
pubmed: 19270709
Immunol Lett. 2019 Dec;216:97-105
pubmed: 31622634
Tumour Biol. 2016 Sep;37(9):11679-11689
pubmed: 27440203
Blood. 2003 Nov 15;102(10):3837-44
pubmed: 12881305
J Immunol. 2009 Jul 15;183(2):993-1004
pubmed: 19561093
PLoS One. 2010 Apr 26;5(4):e10088
pubmed: 20436665
Biochem Biophys Res Commun. 2005 May 13;330(3):633-40
pubmed: 15809044
Oncogene. 2013 Sep 12;32(37):4343-54
pubmed: 23085755
J Pharmacol Exp Ther. 2011 Jul;338(1):134-42
pubmed: 21505059
Cancer Cell. 2011 Feb 15;19(2):257-72
pubmed: 21316604
Bull Cancer. 2006 Aug;93(8):E73-80
pubmed: 16935775
Cancer Res. 2011 Jan 15;71(2):614-24
pubmed: 21224357
Vaccines (Basel). 2016 Nov 08;4(4):
pubmed: 27834810
Curr Immunol Rev. 2010 May 1;6(2):137-148
pubmed: 20490366
Microcirculation. 1999 Jun;6(2):127-40
pubmed: 10466115
Methods Mol Biol. 2012;904:173-90
pubmed: 22890932
Oncotarget. 2010 Nov;1(7):662-73
pubmed: 21317461
Biochem Biophys Res Commun. 2014 Mar 7;445(2):381-7
pubmed: 24525123
Lupus. 2018 Jun;27(7):1053-1064
pubmed: 29631514
Stem Cells. 2006 Mar;24(3):679-85
pubmed: 16179428
Nat Rev Immunol. 2008 Sep;8(9):726-36
pubmed: 19172693
Biol Blood Marrow Transplant. 2001;7(11):581-8
pubmed: 11760145
Curr Med Res Opin. 2016;32(3):555-62
pubmed: 26652645
PLoS One. 2012;7(10):e47559
pubmed: 23133515
Cytotherapy. 2012 Mar;14(3):285-95
pubmed: 22264191
Stem Cells. 2007 Jan;25(1):69-77
pubmed: 16973831
Mol Cancer. 2010 Nov 18;9:295
pubmed: 21087507
Oncol Lett. 2016 Jun;11(6):4264-4268
pubmed: 27313776
Mol Cancer Ther. 2014 Apr;13(4):962-75
pubmed: 24502925
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3423-3427
pubmed: 29286614